Published in Cancer Res on December 01, 1967
The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol (1994) 2.64
Participation of c-myc protein in DNA synthesis of human cells. Science (1986) 2.22
Selective inhibition of the cell cycle of cultured human diploid fibroblasts by aminonucleoside of puromycin. J Cell Physiol (1973) 1.50
The Muir-Torre (Torre's) syndrome: the significance of a solitary sebaceous tumor. J Am Acad Dermatol (1990) 1.49
Epidermolysis bullosa associated with congenital localized absence of skin, fetal abdominal mass, and pyloric atresia. Pediatr Dermatol (1998) 1.48
Thymidine as a synchronizing agent. I. Nucleic acid and protein formation in synchronous HeLa cultures treated with excess thymidine. J Cell Physiol (1969) 1.45
Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res (1996) 1.45
Culture of Vibrio extorquens from severe, chronic skin ulcers in a Puerto Rican woman. J Am Acad Dermatol (1983) 1.43
Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J Cell Biochem (2001) 1.34
Erythroderma: review of a potentially life-threatening dermatosis. Indian J Dermatol (2009) 1.27
Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis. J Cell Physiol (1967) 1.21
An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures. In Vitro (1973) 1.16
Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Inst (2001) 1.15
Thymidine as a synchronizing agent. II. Partial recovery of HeLa cells from unbalanced growth. J Cell Physiol (1969) 1.07
Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells. Exp Cell Res (2000) 1.05
Thymidine as synchronizing agent. 3. Persistence of cell cycle patterns of phosphatase activities and elevation of nuclease activity during inhibition of DNA synthesis. J Cell Physiol (1970) 1.04
A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25-dihydroxycholecalciferol. Proc Soc Exp Biol Med (1985) 1.03
Nevus comedonicus. Dermatology (1999) 1.03
Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp Cell Res (2000) 1.01
Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem (2001) 0.99
Penile Kaposi's sarcoma preceded by chronic penile lymphoedema. Br J Dermatol (2000) 0.97
Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3. Cancer Res (1985) 0.97
Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem (1997) 0.96
Teniposide induces nuclear but not mitochondrial DNA degradation. Cancer Res (1992) 0.96
Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood (2001) 0.95
The nosology of parapsoriasis. J Am Acad Dermatol (1981) 0.95
Differentiation-related mechanisms which suppress DNA replication. Exp Cell Res (1999) 0.93
Co-recessive inheritance: a model for DNA repair, genetic disease and carcinogenesis. Mutat Res (1985) 0.93
Calcinosis cutis associated with secondary hyperparathyroidism due to renal failure. Int J Dermatol (1996) 0.93
Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells. Exp Cell Res (2001) 0.93
Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3. J Natl Cancer Inst (1997) 0.93
Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant. Leukemia (2005) 0.92
Oral lesions in lepromatous leprosy. J Oral Med (1987) 0.91
Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res (1997) 0.91
Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region. Oncogene (2006) 0.91
Loss of deoxcytidine kinase expression and tetraploidization of HL60 cells following long-term culture in 1,25-dihydroxyvitamin D3. Exp Cell Res (1996) 0.90
Relationship between RNA synthesis, cell division, and morphology of mammalian cells. I. Puromycin aminonucleoside as an inhibitor of RNA synthesis and division in HeLa cells. J Cell Biol (1966) 0.89
Dermatofibrosarcoma non-protuberans: description and report of five cases of a morpheaform variant of dermatofibrosarcoma. J Surg Oncol (1985) 0.89
Pyoderma vegetans. J Cutan Med Surg (2001) 0.89
Binding properties of bovine ocular lens zeta-crystallin to right-handed B-DNA, left-handed Z-DNA, and single-stranded DNA. Cell Biol Int (1998) 0.87
Cytologic appearance of the nucleolus of normal and neoplastic cells in relation to the synthesis of RNA. Acta Cytol (1972) 0.87
Defective DNA endonuclease activities in Fanconi's anemia cells, complementation groups A and B. Mutat Res (1992) 0.87
Florid cutaneous papillomatosis, malignant acanthosis nigricans, and pulmonary squamous cell carcinoma. Int J Dermatol (1991) 0.87
The treatment of atypical lipoma with liposuction. J Dermatol Surg Oncol (1991) 0.86
Correction of the DNA repair defect in Fanconi anemia complementation groups A and D cells. Biochem Biophys Res Commun (1997) 0.86
Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids (2001) 0.86
A correlated morphological and functional study of the effects of actinomycin D on HeLa cells. I. Effects on the nucleolar and cytoplasmic ribonucleoproteins. Exp Cell Res (1967) 0.86
Bacillary angiomatosis: presentation of six patients, some with unusual features. Br J Dermatol (1997) 0.86
Ecchymotic Kaposi's sarcoma. Cutis (1995) 0.86
Mitomycin C induced increases in the activities of the deoxyribonucleases of HeLa cells. Biochem Biophys Res Commun (1966) 0.85
Intraoral melanoacanthoma. J Surg Oncol (1984) 0.85
Differences between diploid and heteroploid cultured mammalian cells in their response to puromycin aminonucleoside. Cancer Res (1968) 0.85
Giant basal cell carcinoma with metastases and myelophthisic anemia. J Surg Oncol (1986) 0.85
Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL60 cells resistant to 1-beta-D-arabinofuranosylcytosine. Cancer Res (1994) 0.84
1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res (1993) 0.83
Autoradiographic studies of the effects of inhibitors of protein synthesis on RNA synthesis in HeLa cells. Exp Cell Res (1968) 0.83
The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms. Dermatologica (1989) 0.83
Acrokeratosis paraneoplastica (Bazex' syndrome). Report of a case and review of the literature. Arch Dermatol (1983) 0.83
Selective inhibition of preribosomal RNA synthesis by puromycin aminonucleoside in transformed human fibroblasts: studies of the nature of the inhibition in isolated nuclei and nucleoli. J Cell Physiol (1979) 0.83
Instability of puromycin. Nature (1966) 0.83
Coordinate expression of c-myc, c-myb, and histone H4 genes in reversibly differentiating HL 60 cells. J Cell Physiol (1987) 0.82
Lowering of p27Kip1 levels by its antisense or by development of resistance to 1,25-dihydroxyvitamin D3 reverses the G1 block but not differentiation of HL60 cells. Leukemia (1998) 0.82
Ectopic expression of truncated Sp1 transcription factor prolongs the S phase and reduces the growth rate. Anticancer Res (2000) 0.82
Erythema dyschromicum perstans. Cutis (1986) 0.82
p53/56(lyn) antisense shifts the 1,25-dihydroxyvitamin D3-induced G1/S block in HL60 cells to S phase. J Cell Physiol (2000) 0.82
Multiple connective tissue nevi. Cutis (1988) 0.81
Origin of antibody-dependent, lymphoid-cell-independent hemolytic plaques in rabbit spleen cell cultures. Proc Soc Exp Biol Med (1975) 0.81
Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL 60 cells. J Natl Cancer Inst (1987) 0.81
Resistance of mitochondrial DNA to degradation characterizes the apoptotic but not the necrotic mode of human leukemia cell death. J Cell Biochem (1993) 0.81
Subcorneal pustular dermatosis with polyarthritis. Cutis (1986) 0.81
DNA repair and chromatin structure in genetic diseases. Prog Nucleic Acid Res Mol Biol (1999) 0.81
Long-term exposure of HL60 cells to 1,25-dihydroxyvitamin D3 reduces their tumorigenicity: a model for cancer chemoprevention. Proc Soc Exp Biol Med (1997) 0.81
Hyperplastic reaction developing within a tattoo. Granulomatous tattoo reaction, probably to mercuric sulfide (cinnabar). Arch Dermatol (1987) 0.80
Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea. J Natl Cancer Inst (1986) 0.80
A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3. Cell Prolif (1994) 0.80
Comparison of apoptosis and terminal differentiation: the mammalian aging process. J Histochem Cytochem (2001) 0.80
Presence and quantification of macrophages in squamous cell carcinoma of the cervix. Int J Gynecol Cancer (2003) 0.80
Genetic diseases associated with DNA and chromosomal instability. Dermatol Clin (1987) 0.80
The quantification and distribution of nasal sebaceous glands using image analysis. Aesthetic Plast Surg (1996) 0.80
Inhibition of DNA synthesis by an inducer of differentiation of leukemic cells, 1 alpha, 25 dihydroxy vitamin D3, precedes down regulation of the c-myc gene. J Cell Physiol (1986) 0.79
Trichoepithelioma in a systematized epidermal nevus with acantholytic dyskeratosis. Its occurrence in a black man. Arch Dermatol (1984) 0.79
Cutaneous signs of selected systemic diseases. J Med (1999) 0.79
Cutaneous fibrous dysplasia: an incomplete form of the McCune-Albright syndrome. Dermatology (1996) 0.79
Truncation of Sp1 transcription factor by myeloblastin in undifferentiated HL60 cells. J Cell Physiol (1998) 0.79
Specific association of increased cyclin-dependent kinase 5 expression with monocytic lineage of differentiation of human leukemia HL60 cells. J Leukoc Biol (2000) 0.79
Definition of the cell cycle segment with special sensitivity to vinblastine. Proc Soc Exp Biol Med (1978) 0.79
Nuclear deoxyribonuclease activities in human lymphoblastoid and mouse melanoma cells. A comparative study. Biochim Biophys Acta (1982) 0.79
Increased expression of oncogene c-Ha-ras during granulocytic differentiation of HL60 cells. Lab Invest (1987) 0.79
Methods for assessment of DNase activity. Methods Cell Biol (1978) 0.79
Prognostic value of morphometry in papillary thyroid carcinoma. Hum Pathol (1989) 0.79
Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy. Br J Dermatol (1996) 0.79
Cutaneous ciliated cyst with interspersed apocrine features presenting as a pilonidal cyst in a child. Pediatr Dev Pathol (2001) 0.79
Cyclin-dependent kinase 6 is the principal target of p27/Kip1 regulation of the G1-phase traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Cancer Res (1997) 0.78
Dermatopathia pigmentosa reticularis. Arch Dermatol (1990) 0.78
Identification of early apoptosis in feulgen-stained cultured cells in situ by computerized image analysis. Cytometry (1998) 0.78
Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells. Blood (1991) 0.78
Terminal differentiation and left-handed Z-DNA: a review. Cell Biol Int (1999) 0.78
Purification and properties of a nuclear DNA endonuclease from HeLa S3 cells. Biochim Biophys Acta (1979) 0.78